Catalyst Pharma Financial Overview
Catalyst Pharma's market cap is currently $2.98B. The company's EPS TTM is $0.42; its P/E ratio is 14.14; Catalyst Pharma is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $0.31. See an overview of income statement, balance sheet, and cash flow financials.
